Acrigen Biosciences
PrivateLast Round
Seed
Sep 28, 2021
Total Funding Raised
$256,580
Company Overview
Acrigen Biosciences is a biotechnology company that develops precision gene editing systems using CRISPR-Cas nucleases and engineered anti-CRISPR proteins to improve the safety and efficacy of genetic therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acrigen Biosciences Comparables
Compare Acrigen Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acrobat Genomics | 79% | |
| Arbor Biotechnologies | 77% | |
| Alia Therapeutics | 76% | |
Acrigen Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 28, 2021 | ||||
| Grant | Dec 12, 2019 |
Acrigen Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Seed |
| Berkeley Catalyst Fund | Seed |
| Alexandria Venture Investments | Seed |
| Red Tree Venture Capital | Seed |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2019
$257K grant awarded by National Institute of General Medical Sciences.
Acrigen Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acrigen Biosciences's valuation, stock price, and market status.